The Id family of helix ± loop ± helix (HLH) proteins are thought to aect the balance between cell growth and dierentiation by negatively regulating the function of basic ± helix ± loop ± helix (bHLH) transcription factors. Although it has been suggested for some time that Id is involved in cell cycle regulation, little is known about the molecular mechanism of this control. Recent studies, however, have revealed that Id binds to important cell cycle regulatory proteins other than bHLH proteins. Two such proteins, pRB (retinoblastoma tumour suppressor protein) family proteins and Ets-family transcription factors are known to play key roles in cell cycle regulation, transformation and tumour suppression. Through the characterization of these pathways we will begin to understand the mechanisms by which Id controls normal and abnormal cell cycle progression. Oncogene (2001) 20, 8317 ± 8325
Introduction
The basic ± helix ± loop ± helix (bHLH) family of transcription factors have been shown to play a key role in the dierentiation of a number of cell lineages, including B-and T-lymphocytes, muscle cells, pancreatic b cells, neurons and osteoblasts (reviewed in Jan and Jan, 1993; Weintraub, 1993; Klein, 1994: Massari and Murre, 2000) . This family of proteins generally contains a helix ± loop ± helix (HLH) dimerization domain, consisting of highly conserved amphipathic helices separated by a loop of variable length and sequence, and an adjacent DNA-binding domain which is rich in basic amino acids (Murre et al., 1989a; Davis et al., 1990; Ellenberger et al., 1994; Ma et al., 1994) . There are two main categories of bHLH proteins. The class A bHLH, also known as the E proteins, such as those encoded by dierentially spliced transcripts from the E2A (E12, E47 and E2-5/ITF1 proteins), E2-2/ITF2 and HEB/HTF4 genes and Daughterless are ubiquitously expressed (Murre et al., 1989b; Henthorn et al., 1990; Zhang et al., 1991; Hu et al., 1992; Skerjanc et al., 1996; Massari and Murre, 2000) whereas class B bHLH proteins, which include members such as MyoD, myogenin, NeuroD/BETA2, MASH, HAND and TAL, show a tissue-restricted pattern of expression. Dimerization is essential for DNA binding and transcriptional activity in vivo (Lassar et al., 1991; Massari and Murre, 2000) and in general, class B bHLH proteins form heterodimers with the class A bHLH proteins with few exception, although the latter can also operate as homodimers (Shen and Kadesch, 1995) . The basic region of each protein is required for binding to DNA, commonly to a region that includes a speci®c sequence motif known as the E-box (CANNTG) (Ephrussi et al., 1985; Kiledjian et al., 1988; Lassar et al., 1989) or the related N-box (CACNAG) (Klambt et al., 1989; Tietze et al., 1992) .
Id is another category of mammalian HLH protein, which was ®rst identi®ed by Benezra et al. in 1990 during a screen for determination factors belonging to the bHLH protein family. So far four members of the Id family, Id1 to Id4, have been identi®ed in mammalian cells (Benezra et al., 1990; Christy et al., 1991; Sun et al., 1991; Biggs et al., 1992; Ellmeier et al., 1992; Deed et al., 1993; Hara et al., 1994; Riechmann et al., 1994; Pagliuca et al., 1995) , apart from its functional homologue, OUT (Narumi et al., 2000) . These proteins do not contain the basic region adjacent to the HLH domain that is essential for speci®c DNA binding in other bHLH proteins. Id proteins bind to both class-A and class-B bHLH proteins and inhibit their ability to bind DNA as homodimeric or heterodimeric complexes. Because of this activity, these proteins were named as Id (inhibitor of DNA binding). In addition to this ability to inhibit DNA binding, the name Id is often taken to re¯ect the potential role of these proteins in inhibiting dierentiation. For example, the expression of Id genes is down-regulated upon dierentiation in many cell types (Benezra et al., 1990; Hara et al., 1991a; Sun et al., 1991; Kreider et al., 1992; Le Jossic et al., 1994; Einarson and Chao, 1995) . Conversely, ectopic expression of Id1 inhibits B-cell development (Sun, 1994) and the dierentiation of muscle (Jen et al., 1992) , myeloid (Kreider et al., 1992) , erythroid (Shoji et al., 1994; Lister et al., 1995) and mammary epithelial cells (Desprez et al., 1995 (Desprez et al., , 1998 .
In many cases, cellular dierentiation is accompanied by cell cycle arrest. It is likely therefore that since Id is able to inhibit dierentiation, this family of proteins may also be involved in cell cycle regulation. Indeed, several lines of evidence suggest that Id proteins play a role in the G0 to S phase transition of the cell cycle. The stimulation of quiescent ®broblasts with serum or growth factors, for example, induce the expression of Id1, Id2 and Id3 (Christy et al., 1991; Deed et al., 1993; Hara et al., 1994; Barone et al., 1994) . Moreover, inhibiting Id protein synthesis by antisense oligonucleotides prevents the re-entry of G0-arrested ®broblasts into the cell cycle (Hara et al., 1994; Barone et al., 1994) . This evidence strongly implicates the Id proteins in cell cycle control. However, the role that each Id member plays in this regulation has been poorly understood. Recent studies have highlighted some of the mechanisms by which Id proteins are able to modulate the cell cycle. In this review, we will discuss possible mechanisms of cell cycle regulation by Id based on these studies.
Id expression in cell cycle
Proliferating cells express at least one, or more commonly multiple, Id genes. In general, expression level of Id genes is high in proliferating cells, and is low or absent in non-proliferating cells such as terminally dierentiated cells with few exceptions (Norton et al., 1998; Norton, 2000) . Indeed, Id3 (HLH462) was originally identi®ed as a delayed early response gene whose expression was induced following mitogenic stimulation in mouse BALB/c 3T3 ®bro-blasts (Christy et al., 1991) . The expression of both Id1 and Id2 transcripts was also observed to rapidly increase (within 1 ± 2 h) following mitogenic stimulation of serum starved primary human ®broblasts (Hara et al., 1994) . Following an initial decline, the expression level of both Id1 and Id2 were further upregulated as cells progressed through G1 and into the S phase of the cell cycle, suggesting that both Id1 and Id2 may have bi-functional roles in the G0 to S phase transition in the cell cycle (Hara et al., 1994) . It is interesting to note that Id2 and Id3 are phosphorylated by cyclin-dependent kinase 2 (CDK2) in late G1 Deed et al., 1997) , implying that phosphorylation of Id2/3 may alter their activity and perhaps allow Id2/3 to bind to other proteins ( Figure  1 ). In addition to cell cycle-linked phosphorylation, Id proteins undergo rapid turnover during the cell cycle with its levels being regulated by the ubiquitinproteosome degradation pathway (Bounpheng et al., 1999) . Thus Id is regulated at multiple levels, i.e. transcriptional regulation, protein stability and posttranslational modi®cation. So far a correlation between Id4 expression and cell growth has not been identi®ed.
Id binding to factors involved in cell cycle regulation
In addition to binding to members of the bHLH family, Id proteins have also been shown to associate with other factors involved in cell cycle regulation. A key player regulating the G0 to S phase transition is the retinoblastoma tumour suppressor protein (pRB) as well as the RB family members, p107 and p130 (Weinberg, 1995; Mulligan and Jacks, 1998; Vooijsand and Berns, 1999) . The activity of pRB-family proteins are mainly regulated by a series of cyclin-dependent kinases (CDKs), including CDK4 and CDK6, acting in conjunction with their regulatory partners, cyclins D1, D2 and D3, and CDK2 in conjunction with cyclins E and A (reviewed in Sherr, 1994 Sherr, , 1996 Sherr and Roberts, 1999) . The current view is that CDK4 and/or CDK6 initiate phosphorylation of the C-terminal region of pRB, leading to successive intramolecular interactions that initially displace histone deacetylase (HDAC) from the pocket domain, blocking active transcriptional repression by pRB. This facilitates a second interaction that leads to phosphorylation and subsequent disruption of the pocket domain by CDK2, preventing pRB from binding to and inactivating E2F transcription factor whose activity is required for entry to S phase ( Figure 2 ) (Harbour et al., 1999) . As critical integrators of mitogenic-signalling pathways, activities of CDKs are regulated at multiple levels, including the synthesis and stability of individual components, the assembly of functional complexes, post-transcriptional modi®cation and binding to CDK inhibitors (CKIs) (Sherr and Roberts, 1999; Sugimoto et al., 1999 ). In contrast to the Kip/Cip family, which inhibits a broad range of CDKs, the INK4 family protein speci®cally binds to and inactivates CDK4 and CDK6 (Serrano et al., 1993; Ruas and Peters, 1998; Sherr and Roberts, 1999) . Iavarone et al. (1994) and Lasorella et al. (1996) have shown that Id2 but not Id1 or Id3 are able to bind to pRB and abolish its growth-suppressing activity. In-vitro analysis of the binding of Id2 and pRB indicated that the binding is dependant on the HLH domain of Id2, and the pocket domain of pRB (Lasorella et al., 1996) . Growth arrest by pRB was not antagonized in transfection studies using Id2 lacking the HLH domain. In addition to pRB binding, Id2 has been shown to associate with p107 and p130 both invitro, and in in-vivo transfection experiments (Lasorella et al., 1996) . Although the HLH region is well conserved between Id family members, only the HLH domain of Id2 was shown to interact with p107 and p130. Evidence suggesting that Id2 but neither Id1 nor Id3 bind to pRB and related proteins implies a distinct functional role which may also be underlined by the expression pattern observed for Id2 in cells. The ®rst increase of Id2 gene expression is observed following mitogenic stimulation of quiescent cells. It is possible that Id2 in this circumstance may have in¯uence over the activity of p130-E2F4/5 complexes, which are believed to be inhibitory complexes for cell growth in G0 phase (Gaubatz et al., 2000; Bruce et al., 2000; Hansen et al., 2001) . The second peak of Id2 expression occurs at late G1, where E2F1-3 are actively repressed by interaction with pRB and/or p107 (Nevins, 1998; Harbour and Dean, 2000; Humbert et al., 2000) . Disruption of this complex by Id2 would release the E2F1-3 from pRB/p107 and facilitate the gene expression required for progression of cells to S phase. These models, however, can not be applied to Lasorella et al. (2000) reported the genetic interaction between Rb and Id2 during development using intercrossed Rb and Id2 mutant mice. In addition, Lasorella et al. (2000) discovered that Id2 is a transcriptional target of both N-myc and c-myc, suggesting that Myc transcription factors increase expression of Id2 to bypass the pRB block and drive progression of G1 to S phase transition. But if Id2 is simply restraining RB, then why is the RB null rescued by loss of Id2? There must be another component which could be the mechanism described below, i.e. that loss of RB leads to too much Id2 which sequesters E proteins and other factors leading to increased CDK activity.
In addition to binding directly to pRB in order to dissociate it from the E2F/DP1 complex, Id proteins may aect the activity of pRB in a dierent manner. It has been suggested that the ubiquitous bHLH protein E2A has the ability to block G1 to S phase transition at least through the transcriptional activation of the p21
Cip1 gene Prabhu et al., 1997) . Id1 and possibly other members of the Id family, are able to inhibit E2A mediated expression of the p21
Cip1 gene (Prabhu et al., 1997) . p21 Cip1 binds to and inactivates CDKs and enhances the activity of pRB, thereby blocking G1 to S phase transition. Therefore, it is possible that Id proteins mediate G1 to S phase transition through the downregulation of p21
Cip1 gene expression by heterodimerization with E2A. Although it is still not clear whether E2A functions as a homodimer or heterodimer in the regulation of p21 Cip1 transcription, it has been reported that overexpression of MyoD also induces p21
Cip1 gene expression (Halevy et al., 1995; Parker et al., 1995) . Therefore, it is likely that E2A heterodimerizes with MyoD in order to regulate p21
Cip1 gene expression at least in myogenic dierentiation and perhaps other class B bHLH proteins in other lineages. Id proteins have been shown to antagonize the activity of the class A and class B heterodimers which could therefore lead to the downregulation of p21 Cip1 and activation of the CDKs in preparation for RB phosphorylation and cell cycle transit. It has been reported that there are two CDK phosphorylation sites, Ser-48 and Ser-154, within the N-terminal domain of E2A. Ser-154 is preferentially phosphorylated by cyclinD1-CDK4, whereas Ser-48 is preferentially phosphorylated by cyclinA-CDK2 or cyclinE-CDK2. Although the growth suppressive activity of E2A is negatively regulated by phosphorylation of Ser-154 by cyclinD1-CDK4, phosphorylation of these sites are not required for inhibition of E2A transcriptional activity by CDKs (Chu and Kohtz, 2001 ). These results suggest that the growth suppressor and transcriptional activator functions of E2A may be distinct. It is therefore interesting to examine whether or not this can be applied to the regulation of p21 Cip1 expression by E12/E47. It is also interesting to note that MyoD directly binds to and inhibits CDK4 through a conserved 15 amino acids domain on the exterior of the bHLH region (Zhang et al., 1999) . Thus, MyoD acts as a CDK inhibitor through two independent mechanisms, ®rstly by directly binding to CDK4 and secondly by inducing p21 Cip1 gene expression.
Id 1 ± 3, have also been shown to bind to other factors which control the response of cells to mitogenic stimulation, such as ternary complex factors (TCFs) (Yates et al., 1999) . These factors, which are a subfamily of ETS domain proteins and include factors such as Elk-1, SAP-1 and SAP2, are involved in the regulation of expression of immediate early genes such as c-fos and egr-1 following mitogenic stimulation or as a response to stress. Binding of Id to the ETS DNA binding domain of these factors, disrupts the binding of SRF and TCF complexes to the serum responsible element (SRE) thus inhibiting transcription of TCF responsive genes. Interestingly, Id1 is under the transcriptional control of EGR-1 (Tournay and Benezra, 1996) , suggesting a negative feed-back loop which may regulate the response of cells to mitogenic stimulation by setting the threshold level for Id expression. In addition, Id1 has been shown to bind to Ets1 and Ets2, regulating expression of the p16 INK4a gene (Ohtani et al., 2001) . This pathway will be further discussed below.
Id and cellular senescence
In contrast to germ line cells and certain stem cells, most somatic cells permanently stop dividing after a ®nite number of cell divisions in culture and enter a state termed cellular or replicative senescence. These cells are irreversibly arrested in the G1 phase of the cell cycle and are no longer able to grow despite remaining viable and metabolically active for long periods of time, thereby distinguishing, senescence from quiescence or programmed cell death (apoptosis) (Campisi et al., 1996) . The ®nite replicative lifespan of cells was ®rst discovered 40 years ago by Hay¯ick and Moorhead (1961) , and cellular senescence is often termed the`Hay¯ick limit'. Most tumours contain cells that appear to have bypassed this limit and evaded senescence. Immortality, or even an extended replicative lifespan, greatly increases the susceptibility to malignant progression because it permits the extensive cell divisions needed to acquire successive mutations. In this sense, cellular senescence could act as a barrier to cancer and play an important role in tumour suppression (Figure 3 ). It could also be a fundamental factor involved in the ageing process. A number of hypotheses have been proposed to explain the mechanisms of cellular senescence, and they can be grouped into two broad categories. One set proposes that the loss of proliferative potential is due to random accumulation of damage or stress, for example through inappropriate culture conditions (Sherr and DePinho, 2000; Tang et al., 2001; Mathon et al., 2001) . The other set proposes that genetically programmed processes, such as those observed in dierentiation, result in cellular senescence . Although much evidence suggests that cellular senescence in human cells is genetically controlled by a cell-division counting mechanism called telomere shortening, recent reports strongly suggest that it can also be induced by physiological stress (Artandi and DePinho, 2000; Wright and Shay, 2000; Sherr and DePinho, 2000; Lundberg et al., 2000) . Both types of mechanisms will likely play a role in cellular senescence.
In both human and rodent cells, the pRB and p53 tumour suppressor proteins are crucial gatekeepers of senescence (Campisi et al., 1996; Carnero et al., 2000) . As mentioned earlier, the activities of RB are highly regulated by CDK4, CDK6 and CDK2. The loss of growth potential is accompanied by elevated expression of p16
INK4a in human senescent cells (Hara et al., 1996a; Alcorta et al., 1996; Loughran et al., 1996; Rezniko et al., 1996) . Overexpression of p16
INK4A causes activation of pRB, resulting in a senescent-like growth arrest (McConnell et al., 1998; Kato et al., 1998 INK4A expression is more likely to be regulated by physiological stress (such as mitogenic stress), than by telomere shortening. This is because accumulation of p16
INK4A is also observed in rodent senescent cells where we cannot observe detectable telomere shortening (Palmero et al., 1997; Zindy et al., 1997) . In addition, Serrano et al. (1997) have shown that aberrant growth signals provided by oncogenic Ras induce p16 INK4A gene expression without telomere shortening in both human and rodent cells. The introduction of oncogenic Ras into normal primary cells results in the induction of various antiproliferative proteins, including the p16 INK4A and p53 tumour suppressors; the accompanying cell cycle arrest resembles cellular senescence and is termed premature senescence'. Normal cells must therefore have a sensor that detects aberrant growth signals such as oncogene activation, and that may induce p16
INK4A . In rodent cells, inactivation of either the p16 INK4A /pRB pathway or p53 pathway seems to be enough to override both replicative senescence and premature senescence (Lundberg et al., 2000) . In human cells, however, inactivation of both pathways is required (Shay et al., 1991; Hara et al., 1991b) . Targeted inactivation of all of the pRB family genes (pRB, p107 and p130) immortalizes mouse cells despite the presence of high levels of p53, suggesting that pRB family proteins play a role downstream of the p53-pathway in mouse cell senescence (Sage et al., 2000; Dannenberg et al., 2000; Peeper et al., 2001) . In human cell senescence on the other hand, p53 Figure 3 Model of cellular senescence. Human cells has at least two dierent barriers to cancer. One is the Hay¯ick limit which is induced by a variety of stress. The other is the telomere limit which is induced by telomere shortening. PDL: Population doubling level and pRB have overlapping, but distinct roles. Although it is still not clear whether or not senescence occurs in vivo, it is clear that senescence is the ®nal common state of a cell provoked by a variety of distinct physiological stimuli/stress.
Loss of Id function has been linked to replicative senescence (Hara et al., 1994) and recent studies suggest that Id, especially Id1, is implicated in the regulation of cell senescence and immortalization (Hara et al., 1996b; Alani et al., 1999; Nickolo et al., 2000) . Id1, for example, has been shown to cooperate with a pRB binding mutant of SV40 large T antigen to reactivate DNA synthesis in senescent human ®broblasts (Hara et al., 1996b) . The role of Id1 has also been shown to extend the replicative lifespan of human keratinocytes (Alani et al., 1999; Nickolo et al., 2000) . Alani et al. (1999) suggested that the ectopic expression of Id1, 2 and 3 extended the life-span of the primary human keratinocytes, but Id1 had the most signi®cant eect and immortalized them. Although Nickolo et al. (2000) failed to immortalize the primary human keratinocytes by overexpression of Id1, they also observed that overexpression of Id1 extended the lifespan of human keratinocytes. Both reports showed increased level of phosphorylated, inactive pRB in Id1 expressing cells (Alani et al., 1999; Nickolo et al., 2000) . Nickolo et al. (2000) also reported that the level of p16
INK4a expression decreased following overexpression of Id1, underlining the suggestion that Id1 regulates pRB activity through the regulation of p16
INK4a expression.
A molecular sensor induces p16 INK4A gene expression in response to oncogenic mutation Previous experiments with Ras mutants, which are unable to activate one or another eector pathway of Ras signalling, have identi®ed the MAP kinase signal transduction pathway as critical for Ras-induced senescence Zhu et al., 1998) . Ohtani et al. (2001) have shown that p16 INK4A expression is controlled by a balance between a positive factor, Ets1/ 2, and a negative factor, Id1. Normally, the Ets1/2 transcription factor is phosphorylated and activated by MAP kinase at a certain point in the cell cycle. However, Id1 expression is also induced by EGR1 in response to MAP kinase signalling (Tournay and Benezra, 1996) . Id1 therefore, counterbalances this activity by binding to and inactivating Ets1/2 function. However, oncogenic Ras/MAP kinase signalling constitutively phosphorylates and activates Ets1/2. This aberrant activation overrides the steady state and results in the induction of p16 INK4A which causes premature senescence. In normal replicative senescence, which is provoked by cumulative cell divisions, expression levels of Ets1 increase whilst Id1 levels decline. Thus, Ets1 induces p16 INK4A expression, aided by the concomitant down regulation of Id1 (Figure 4) . In this way, the balance between Ets1/2 and Id1 seems to act as a sensor that detects aberrant growth signals (mitogenic stress/oncogenic stress). These ideas are consistent with recent reports that mouse embryo ®broblasts (MEFs) derived from Id1-de®cient mice express high levels of p16
INK4a (Lyden et al., 1999) . It is clear, however, that it is important to determine whether additional factors are involved in the regulation of p16
INK4A . Indeed, it has been reported that bmi-1, JunB, 14-3-3s and LMP1 also regulate p16 INK4A expression (Jacobs et al., 1999; Passegue and Wagner, 2000; Dellambra et al., 2000; Yang et al., 2000) . Moreover, Id3 expression is induced by Ras-ERK MAP kinase cascade (Bain et al., 2001) . It is therefore likely that the activity of Ets1/2 is regulated by several dierent factors. Understanding the mechanisms of p16 INK4A regulation might help us to ®nd a way of controlling its expression and inducing senescence in cancer. 
Final comments
In addition to the pRB-and Ets-family proteins, three additional non-bHLH proteins, MIDA1 (Shoji et al., 1995; Inoue et al., 2000) , Pax transcription factors (Roberts et al., 2001 ) and adenovirus E1A protein (Nakajima et al., 1998) also interact with Id proteins. Therefore, Id is likely to have dierent functions depending on the binding target. Much work remains to be done in order to fully understand the mechanisms of action of each Id family protein in cell cycle control. It is clear from evidence of overlapping expression during cell cycle progression, that each Id family member is responsible for dierent eects on growth regulation. Additionally, the dierences of binding speci®cities as well as regulation by phosphorylation also underline the dierences in function of each member. Further work is needed to de®ne pathways which control expression of the Id proteins and to identify target genes whose expression is regulated by Id.
